<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04811417</url>
  </required_header>
  <id_info>
    <org_study_id>2018/7798/I</org_study_id>
    <nct_id>NCT04811417</nct_id>
  </id_info>
  <brief_title>Frailty Assessment Among Kidney Transplant Candidates</brief_title>
  <acronym>Mar-Kid</acronym>
  <official_title>Frailty Assessment Among Kidney Transplant Candidates on the Waiting List</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Parc de Salut Mar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Parc de Salut Mar</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Frailty is common among chronic kidney disease patients who are on the kidney transplant (KT)&#xD;
      waiting list.&#xD;
&#xD;
      The aim of this study is to assess frailty according to different frailty tools among KT&#xD;
      candidates and to establish potential biomarkers of frailty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational study where KT candidates will be assessed for frailty according to:&#xD;
&#xD;
        -  Frailty Fried Phenotype and&#xD;
&#xD;
        -  FRAIL scale&#xD;
&#xD;
      Sociodemographics and clinical variables will be collected and serum samples will be obtained&#xD;
      in order to implement further studies regarding biomarkers of frailty..&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2015</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of frailty among KT candidates</measure>
    <time_frame>2015-2020</time_frame>
    <description>Prevalence of frailty according FRIED and FRAIL scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biomarkers of frailty among KT candidates</measure>
    <time_frame>2015-2020</time_frame>
    <description>Serum samples for biomarkers</description>
  </primary_outcome>
  <enrollment type="Actual">500</enrollment>
  <condition>Frailty</condition>
  <condition>Kidney Transplant; Complications</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        KT candidates (&gt;18 years-old) accepted for the KT waiting list and willing to participate&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  KT candidates accepted for the KT waiting list&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No willing for participating&#xD;
&#xD;
          -  Difficulty in understanding Spanish or English&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 19, 2021</study_first_submitted>
  <study_first_submitted_qc>March 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Parc de Salut Mar</investigator_affiliation>
    <investigator_full_name>M José Pérez Sáez</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Frailty</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

